Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. [electronic resource]
Producer: 20130828Description: 2556-65 p. digitalISSN:- 1538-8514
- Animals
- Anoikis -- drug effects
- Cell Adhesion -- drug effects
- Cell Line, Tumor
- Disease Progression
- Female
- Humans
- Immunohistochemistry
- Mice
- Mice, Inbred NOD
- Mice, SCID
- MicroRNAs -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- pharmacology
- Transduction, Genetic -- methods
- Transfection
- Tubulin -- biosynthesis
- Tumor Burden
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.